Description
The National Institutes of Health (NIH) is seeking to purchase two CD Leycom INCA Pressure-Volume Loop Systems for the National Heart, Lung, and Blood Institute (NHLBI) Laboratory of Cardiovascular Intervention (LCI) SESAME clinical studies. The systems must have FDA 510(k) market clearance for use in human patients and possess specific salient characteristics, including invasive conductance-catheter-based pressure-volume recording capability and support for load-independent assessment of ventricular function. The desired delivery date is on or before August 1, 2026.
• The systems must be compatible with 7F disposable conductance catheters bearing 12 electrodes at 8 mm electrode spacing.
• The offeror must provide a completed copy of FAR 52.212-3, Offeror Representations and Certifications—Commercial Items, with their offer.
• The offeror must be actively registered in the System for Award Management (SAM) at www.sam.gov.
• The evaluation factors may include past performance, technical capability, special features, trade-in considerations, expected lifecycle, warranty, maintenance availability, and environmental or energy efficiency considerations.